Bluesky Facebook Reddit Email

COVID-19 vaccine reactogenicity among young children

11.25.24 | JAMA Network

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

About The Study: No unexpected reactions were identified in this analysis of reactions to COVID-19 vaccines among children. Similar to this study, data from clinical trials and V-safe found that irritability was the most common systemic reaction among children ages 6 months to younger than 2 years, followed by fever and fatigue or sleepiness. In contrast to other studies observing a higher prevalence of reactions after the second COVID-19 vaccine dose, this study observed a higher prevalence after the first dose. This difference may reflect maternal vaccination; the first COVID-19 vaccination in this cohort may be some children’s second immunological encounter with a COVID-19 vaccine.

Corresponding Author: To contact the corresponding author, Andrea J. Sharma, PhD, MPH, email aec4@cdc.gov .

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2024.47492)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47492?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112524

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Keywords

Article Information

Contact Information

JAMA Network Media Relations
JAMA Network
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2024, November 25). COVID-19 vaccine reactogenicity among young children. Brightsurf News. https://www.brightsurf.com/news/147XPOJ1/covid-19-vaccine-reactogenicity-among-young-children.html
MLA:
"COVID-19 vaccine reactogenicity among young children." Brightsurf News, Nov. 25 2024, https://www.brightsurf.com/news/147XPOJ1/covid-19-vaccine-reactogenicity-among-young-children.html.